Results 231 to 240 of about 27,643 (258)

Tight Phosphate Control in ESKD Patients Is Warranted: PRO. [PDF]

Kidney360
Song RM, Sprague SM.
europepmc   +1 more source

White phosphorus munitions: pathophysiology, clinical management, and multidisciplinary perspectives on burn injuries and humanitarian challenges. [PDF]

Front Public Health
Wang M, Bai Y, Zhang X, Zhang J, Kang A.
europepmc   +1 more source

Evaluating the Effectiveness of Mobile Apps on Medication Adherence for Chronic Conditions: Systematic Review and Meta-Analysis.

J Med Internet Res
Lanke V, Trimm K, Habib B, Tamblyn R.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Causes of Hypo- and Hyperphosphatemia in Humans

Calcified Tissue International, 2020
Eugenie Koumakis, Christian Roux, Karine Briot   +2 more
exaly   +2 more sources

Targeted perfusion adsorption for hyperphosphatemia using mixed matrix microspheres (MMMs) encapsulated NH2-MIL-101(Fe).

Journal of materials chemistry. B, 2021
Hyperphosphatemia, a common complication of chronic renal failure patients, is described as an excess amount of serum phosphate >4.5 mg dL-1. Current therapy for hyperphosphatemia is limited by low removal efficiency, secondary hyperparathyroidism ...
Wenhui Chen, Qiu Han, Yang Liu, Yiwen Wang, Fu Liu   +4 more
semanticscholar   +1 more source

Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders

American Journal of Kidney Diseases, 2016
Richard A Sherman
exaly   +2 more sources

Improvement in Hyperphosphatemia Using Phosphate Education and Planning Talks.

Journal of renal nutrition, 2019
OBJECTIVE Hyperphosphatemia is a common complication in patients with end-stage renal disease on hemodialysis. The mainstay of phosphate management involves a low-phosphate diet and use of phosphate binders, yet these are often insufficient.
Alexander F. L. Brauer, S. Waheed, T. Singh, Laura Maursetter   +3 more
semanticscholar   +1 more source